Psychiatric Morbidity Decreased After Assisted Reproductive Technology Treatment
These analyses may serve clinicians in addressing potential psychiatric obstacles in patients undergoing fertility treatments.
These analyses may serve clinicians in addressing potential psychiatric obstacles in patients undergoing fertility treatments.
Researchers identified factors associated with regret following elective oocyte cryopreservation among 201 women undergoing fertility preservation between 2012 and 2016.
Researchers tested whether semen quality and reproductive function could be a marker of general health in men.
Variable improvements in menses, hormones, and metabolism were seen during 24 months of metformin use in 119 women with PCOS sub-grouped by baseline weight and androgen status.
Study raises the question of whether treatment with thyroid hormone replacement for individuals with TSH levels >2.5 mIU/L may be an economical first step in treating unexplained infertility.
Researchers used the Family Planning Estimation Tool to evaluate the performance of 68 of the 69 countries involved in the Family Planning 2020 initiative.
Although the use of fertility therapy has steadily increased in the past few decades, research findings pertaining to related long-term cardiovascular outcomes are scarce and conflicting.
Women with hypertensive disorders during pregnancy have a significantly greater risk for future cardiovascular disease when compared with normotensive expecting mothers.
Between 2005 and 2014, the prevalence of chronic conditions increased across all segments of the childbearing population.
Long-term exposure to progestin-only oral contraceptives or to a progestin intrauterine device is associated with a small beneficial effect on pelvic girdle pain.